Almirall, S.A.: Keratosis, Actinic trials

The registry lists 14 Keratosis, Actinic studies with Almirall, S.A. as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 2 3Phase 3 7Phase 4 2No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic KeratosisCompletedNCT06135415Phase 3Results posted
• A Study of Tirbanibulin on the Wellbeing of Participants With Actinic KeratosesCompletedNCT05741294Phase 4Results posted
• A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic KeratosisCompletedNCT05279131Phase 3Results posted
• Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic KeratosisCompletedNCT05260073Results posted
• A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)CompletedNCT03285490Phase 3Results posted
• A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or ScalpCompletedNCT03285477Phase 3Results posted
• Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or ScalpCompletedNCT02838628Phase 2Results posted
• UV Sensor in Patients With Actinic KeratosisCompletedNCT05481073
• A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or ScalpActive, not recruitingNCT05387525Phase 4
• Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic KeratosesCompletedNCT02289768Phase 3
• LAS41005 in Hyperkeratotic Actinic KeratosisCompletedNCT01358851Phase 2
• Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic KeratosisCompletedNCT01265602Phase 3
• Efficacy and Safety Study of LAS41007 in the Treatment of Actinic KeratosisCompletedNCT00991861Phase 2
• Study on the Efficacy of LAS41005 in the Treatment of Actinic KeratosisCompletedNCT00987246Phase 3